J. Mark Jackson, MD, Dermatology Specialists, PSC, Louisville, KY, United States; Erin Boh, MD, Tulane Medical School, New Orleans, LA, United States; Drore Eisen, MD, private practice, Cincinnati, OH, United States; Amy H. Xia, PhD, Amgen Inc., Thousand Oaks, CA, United StatesLe texte complet de cet article est disponible en PDF.
Dr. Jackson has performed research or received consulting, honoraria and/or support from the following companies: 3M Pharmaceuticals, Amgen, Biogen, Collagenix, Connetics, Ferndale, Galderma, Genentech, Medicis, Novartis, and Roche.
Dr. Erin Boh has no financial interests in any biologic manufactures and is a member of the speakers bureau for the following companies: Amgen, Biogen, and Genentech.
Research funded by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research